Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?

Suppr

超能文献

作者信息

Ahmadi Tahamtan, Schuster Stephen J

出版信息

J Clin Oncol. 2009 Feb 1;27(4):479-80. doi: 10.1200/JCO.2008.18.8698. Epub 2008 Dec 15.

DOI:10.1200/JCO.2008.18.8698

PMID:19075263

Abstract

摘要

相似文献

Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?

J Clin Oncol. 2009 Feb 1;27(4):479-80. doi: 10.1200/JCO.2008.18.8698. Epub 2008 Dec 15.

Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.利妥昔单抗联合氟达拉滨和环磷酰胺或其他药物治疗慢性淋巴细胞白血病。

Expert Rev Anticancer Ther. 2010 Oct;10(10):1529-43. doi: 10.1586/era.10.132.

Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.低剂量氟达拉滨、环磷酰胺与高剂量利妥昔单抗联合化疗免疫疗法用于既往未治疗的慢性淋巴细胞白血病患者。

J Clin Oncol. 2009 Feb 1;27(4):498-503. doi: 10.1200/JCO.2008.17.2619. Epub 2008 Dec 15.

Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.慢性淋巴细胞白血病患者尽管接受了利妥昔单抗、氟达拉滨和环磷酰胺治疗仍发生副肿瘤性天疱疮

Eur J Dermatol. 2008 Nov-Dec;18(6):717-8. doi: 10.1684/ejd.2008.0528.

Changing the way we think about chronic lymphocytic leukemia.

J Clin Oncol. 2005 Jun 20;23(18):4009-12. doi: 10.1200/JCO.2005.08.964. Epub 2005 Mar 14.

Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.

Br J Haematol. 2007 Nov;139(4):622-3. doi: 10.1111/j.1365-2141.2007.06848.x.

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.氟达拉滨联合环磷酰胺加或不加奥布利默森钠（Bcl-2反义核酸）治疗复发或难治性慢性淋巴细胞白血病的随机III期试验。

J Clin Oncol. 2007 Mar 20;25(9):1114-20. doi: 10.1200/JCO.2006.07.1191. Epub 2007 Feb 12.

Monoclonal antibodies in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的单克隆抗体

Expert Rev Anticancer Ther. 2006 Sep;6(9):1231-8. doi: 10.1586/14737140.6.9.1231.

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.利妥昔单抗、氟达拉滨、环磷酰胺和米托蒽醌：一种用于慢性淋巴细胞白血病的新型高效化学免疫治疗方案。

J Clin Oncol. 2009 Sep 20;27(27):4578-84. doi: 10.1200/JCO.2009.22.0442. Epub 2009 Aug 24.

[Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].

Orv Hetil. 2005 Aug 21;146(34):1791-3.

引用本文的文献

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.利妥昔单抗、奥法木单抗及其他用于慢性淋巴细胞白血病的抗CD20单克隆抗体

Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD008079. doi: 10.1002/14651858.CD008079.pub2.

Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results.非胃黏膜边缘区 B 细胞淋巴瘤：临床病理特征和治疗结果。

Ann Hematol. 2011 Dec;90(12):1399-407. doi: 10.1007/s00277-011-1226-z. Epub 2011 Apr 8.

Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.用于非霍奇金淋巴瘤的单克隆抗体：现状与展望

Clin Dev Immunol. 2010;2010:428253. doi: 10.1155/2010/428253. Epub 2011 Mar 6.

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.利妥昔单抗：在慢性淋巴细胞白血病、低级别或滤泡性淋巴瘤以及弥漫性大 B 细胞淋巴瘤中的应用综述。

Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验